Approval · Notice of Compliance 24571 · 2020
HYRIMOZ: Notice of Compliance 24571
Issued November 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24571
- Date
- November 4, 2020
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New filll volume and manufacturing facility
- Canadian reference product
- HUMIRA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYRIMOZ | 02505258 | Marketed |
| HYRIMOZ | Not yet assigned | — |
Medicinal ingredients
- ADALIMUMAB 20 MG per 0.4ML
- ADALIMUMAB 40 MG per SYR
- ADALIMUMAB 40 MG per 0.8ML